Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: The need for agreement in assessment FISH analysis to avoid diagnostic errors

Histology and Histopathology

Volumn 26, Issue 9, 2011, Pages 1207-1213

  Brunelli, Matteo ^a   Fiorentino, Michelangelo ^b   Gobbo, Stefano ^a   Sperandio, Nicola ^a   Cheng, Liang ^c   Cossu Rocca, Paolo ^d   Segala, Diego ^a   Eble, John Nelson ^c   Delahunt, Brett ^e   Novara, Giacomo ^f   Ficarra, Vincenzo ^f   Martignoni, Guido ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF SASSARI   (Italy)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chromosome 3; Chromosome 3p; Clear cell renal carcinoma; Fluorescence in situ hybridization (FISH); Interphase

Indexed keywords

ADENOCARCINOMA; ANIMAL; CELL NUCLEUS; CHROMOSOME 3; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KIDNEY; KIDNEY TUMOR; PATHOLOGY; POLYPLOIDY; REVIEW;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; CELL NUCLEUS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY; KIDNEY NEOPLASMS; POLYPLOIDY;

EID: 80053215358     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Barocas D.A., Mathew S., DelPizzo J.J., Vaughan E.D. Jr, Sosa R.E., Fine R.G., Akhtar M. and Scherr D.S. (2007). Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int. 99, 290-295.
2. Barocas D.A., Rohan S.M., Kao J., Gurevich R.D., Del Pizzo J.J., Vaughan E.D. Jr, Akhtar M., Chen Y.T. and Scherr D.S. (2006). Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J. Urol. 176, 1957-1962.
3. Brauch H., Weirich G., Brieger J., Glavac D., Rodl H., Eichinger M., Feurer M., Weidt E., Puranakanitstha C., Neuhaus C., Pomer S., Brenner W., Schirmacher P., Storkel S., Rotter M., Masera A., Gugeler N. and Decker H.J. (2000). VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 60, 1942-1948.
4. Brunelli M., Eble J.N., Zhang S., Martignoni G. and Cheng L. (2003a). Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod. Pathol. 16, 1053-1059.
5. Brunelli M., Eble J.N., Zhang S., Martignoni G. and Cheng L. (2003b). Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod. Pathol. 16, 1060-1063.
6. Brunelli M., Gobbo S., Cossu-Rocca P., Cheng L., Ficarra V., Novara G., Menestrina F., Chilosi M. and Martignoni G. (2008). Fluorescent cytogenetics in renal cell neoplasms. Pathologica 100, 455-461.
7. Cossu-Rocca P., Eble J.N., Delahunt B., Zhang S., Martignoni G., Brunelli M. and Cheng L. (2006). Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod. Pathol. 19, 488-493.
8. Eble J.N., Sauter G., Epstein J.I. and Sesterhenn I.A. (2004). WHO: Tumours of the Urinary System and Male Genital Organs. IARC Press.
9. Lyon. Gisselsson D. (2003). Chromosome instability in cancer: how, when, and why? Adv. Cancer Res. 87, 1-29.
10. Gisselsson D. and Hoglund M. (2005). Connecting mitotic instability and chromosome aberrations in cancer--can telomeres bridge the gap? Semin. Cancer Biol. 15, 13-23.
11. Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.M., Lubensky I., Duan D.R., Florence C., Pozzatti R., Walther M.M., Bander N.H., Grossman H.B., Brauch H., Power S., Brooks J.D., Isaacs W.B., Lerman M.I., Zhar B and Linchon W.M. (1994). Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7, 85-90.
12. Gobbo S., Eble J.N., Grignon D.J., Martignoni G., MacLennan G.T., Shah R.B., Zhang S., Brunelli M. and Cheng L. (2008a). Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 32, 1239-1245.
13. Gobbo S., Eble J.N., Maclennan G.T., Grignon D.J., Shah R.B., Zhang S., Martignoni G., Brunelli M. and Cheng L. (2008b). Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am. J. Surg. Pathol. 32, 1780-1786.
14. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.S., Gnarra J.R., Linehan W.M. and et al. (1994). Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. U S A 91, 9700-9704.
15. Hopman A.H., Poddighe P.J., Smeets A.W., Moesker O., Beck J.L., Vooijs G.P. and Ramaekers F.C. (1989). Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am. J. Pathol. 135, 1105-1117.
16. Hopman A.H., Ramaekers F.C., Raap A.K., Beck J.L., Devilee P., van der Ploeg M. and Vooijs G.P. (1988). In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 89, 307-316.
17. Hopman A.H., van Hooren E., van de Kaa C.A., Vooijs P.G. and Ramaekers F.C. (1991). Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod. Pathol. 4, 503-513.
18. Hopman A.H., Voorter C.E. and Ramaekers F.C. (1994). Detection of genomic changes in cancer by in situ hybridization. Mol. Biol. Rep. 19, 31-44.
19. Jones T.D., Eble J.N. and Cheng L. (2005). Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin. Lab. Med. 25, 279-303.
20. Kardas I., Mrozek K., Babinska M., Krajka K., Hadaczek P., Lubinski J., Roszkiewicz A., Kuziemska E. and Limon J. (2005). Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol. Rep. 13, 949-956.
21. Kernek K.M., Brunelli M., Ulbright T.M., Eble J.N., Martignoni G., Zhang S., Michael H., Cummings O.W. and Cheng L. (2004). Fluorescence in situ hybridization analysis of chromosome 12p in paraffinembedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod. Pathol. 17, 1309-1313.
22. Kovacs G. (1994). The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours. World J. Urol. 12, 64-68.
23. Moch H., Schraml P., Bubendorf L., Richter J., Gasser T.C., Mihatsch M.J. and Sauter G. (1998). Intratumoral heterogeneity of von Hippel- Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res. 58, 2304-2309.
24. Nagao K., Yamaguchi S., Matsuyama H., Korenaga Y., Hirata H., Yoshihiro S., Fukunaga K., Oba K. and Naito K. (2005). Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma. Cancer Genet. Cytogenet. 160, 43-48.
25. Receveur A.O., Couturier J., Molinie V., Vieillefond A., Desangles F., Guillaud-Bataille M., Danglot G., Coullin P. and Bernheim A. (2005). Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. Cancer Genet. Cytogenet. 158, 110-118.
26. Sanjmyatav J., Schubert J. and Junker K. (2005). Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis. Oncol. Rep. 14, 1183-1187.
27. Sauter G., Carroll P., Moch H., Kallioniemi A., Kerschmann R., Narayan P., Mihatsch M.J. and Waldman F.M. (1995). c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am. J. Pathol. 146, 1131-1139.
28. Sauter G., Deng G., Moch H., Kerschmann R., Matsumura K., De Vries S., George T., Fuentes J., Carroll P., Mihatsch M.J. and et al. (1994). Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am. J. Pathol. 144, 756-766.
29. Siebert R., Jacobi C., Matthiesen P., Zuhlke-Jenisch R., Potratz C., Zhang Y., Stockle M., Kloppel G., Grote W. and Schlegelberger B. (1998). Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics. J. Urol. 160, 534-539.
30. Tibiletti M.G. (2007). Interphase FISH as a new tool in tumor pathology. Cytogenet. Genome Res. 118, 229-236.
31. Velickovic M., Delahunt B., Storkel S. and Grebem S.K. (2001). VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res. 61, 4815-4819.
32. Wada Y., Igawa M., Shiina H., Shigeno K., Yokogi H., Urakami S., Yoneda T. and Maruyama R. (1998). Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma. Br. J. Cancer 77, 2003-2007.
33. Wagner U., Sauter G., Moch H., Novotna H., Epper R., Mihatsch M.J. and Waldman F.M. (1995). Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum. Pathol. 26, 970-978.
34. Yamaguchi S., Yoshihiro S., Matsuyama H., Nagao K., Fukunaga K., Matsumoto H., Matsuda K., Oba K. and Naito K. (2003). The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma. Clin. Genet. 63, 184-191.
35. Zbar B. (1995). Von Hippel-Lindau disease and sporadic renal cell carcinoma. Cancer Surv. 25, 219-232.